Adamas scores $40M, Navy funds to tackle the flu
Adamas Pharmaceuticals, one of Mohr Davidow Ventures‘ key life science investments, has raised $40 million in a fourth round of funding to develop antiviral treatments for the flu virus. Based in Emeryville, Calif., the company also just signed a research agreement with the U.S. Navy to accelerate drug development in this area.
The funding is significant not only due to its size in a lean time for life science companies, but also because the flu has… Continue Reading
MDV hires pros to find personalized medicine investments
Mohr Davidow Ventures, a Menlo Park, Calif. firm, has hired two biotech experts to help it make prudent investments in personalized healthcare companies. Essentially, they will look for startups that apply technology to give patients more control over their medical experiences, and to cut costs for care providers and drug developers.
Daniel Riskin — who actually worked as a surgeon before entering industry — and Phyllis Whiteley both have firsthand experience at biotechnology companies. Riskin, named… Continue Reading